Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
ConclusionsThe study demonstrated that hUCB-MSC therapy was cost effective compared with microfracture when treating patients with knee OA. These findings should inform health policy decision makers about considerations for cost-effective therapy for treating knee OA to ultimately enhance population health.
Source: Applied Health Economics and Health Policy - Category: Health Management Source Type: research
More News: Clinical Trials | Databases & Libraries | Economics | Health Insurance | Health Management | Insurance | Orthopaedics | Osteoarthritis | Sodium | South Korea Health | Stem Cell Therapy | Stem Cells | Study